Would you ever consider managing HR+ DCIS non-surgically?
If so, in what situations?
Answer from: Medical Oncologist at Academic Institution
In the wake of the COVID-19 pandemic, I think we've all gained experience managing early stage (0-1) HR+ breast cancers with endocrine therapy as a stop-gap until surgery was possible. However, outside of a clinical trial or unusual circumstances, I would not normally consider managing HR+ DCIS non-...
Comments
Medical Oncologist at Aspirus UW Cancer Center I agree
Medical Oncologist at MedStar Washington Hospital Center, MedStar Georgetown University Hospital Dr. @Tevaarwerk,
Would you consider managin...
I agree
Dr. @Tevaarwerk, Would you consider managin...